EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evidence for decreased copper associated with demyelination in the corpus callosum of cuprizone-treated mice

James B W Hilton, Kai Kysenius, Jeffrey R Liddell, Stephen W Mercer, Dominic J Hare, Gojko Buncic, Bence Paul, YouJia Wang, Simon S Murray, Trevor J Kilpatrick, Anthony R White, Paul S Donnelly und 1 weitere

Metallomics · 2024

DOI: 10.1093/mtomcs/mfad072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metallomics, 2024. Verfasst von James B W Hilton und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy & Physiology, The University of Melbourne, Victoria 3010, Australia. Hauptthemen laut MEDLINE: Cuprizone, Demyelinating Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Michael Hirshorn Medical Research Commercialisation Fund, Australian Research Council, Agilent Technologies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Demyelination within the central nervous system (CNS) is a significant feature of debilitating neurological diseases such as multiple sclerosis and administering the copper-selective chelatorcuprizone to mice is widely used to model demyelination in vivo. Conspicuous demyelination within the corpus callosum is generally attributed to cuprizone's ability to restrict copper availability in this vulnerable brain region. However, the small number of studies that have assessed copper in brain tissue from cuprizone-treated mice have produced seemingly conflicting outcomes, leaving the role of CNS copper availability in demyelination unresolved. Herein we describe our assessment of copper concentrations in brain samples from mice treated with cuprizone for 40 d. Importantly, we applied an inductively coupled plasma mass spectrometry methodology that enabled assessment of copper partitioned into soluble and insoluble fractions within distinct brain regions, including the corpus callosum. Our results show that cuprizone-induced demyelination in the corpus callosum was associated with decreased soluble copper in this brain region. Insoluble copper in the corpus callosum was unaffected, as were pools of soluble and insoluble copper in other brain regions. Treatment with the blood–brain barrier permeant copper compound CuII(atsm) increased brain copper levels and this was most pronounced in the soluble fraction of the corpus callosum. This effect was associated with significant mitigation of cuprizone-induced demyelination. These results provide support for the involvement of decreased CNS copper availability in demyelination in the cuprizone model. Relevance to human demyelinating disease is discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CuprizoneDemyelinating DiseasesHumansAnimalsMiceCorpus CallosumCopperOligodendrogliaMice, Inbred C57BLDisease Models, AnimalMyelin Sheath

Stichwörter der Autor:innen

Cu(atsm)coppercorpus callosumcuprizonedemyelinationmultiple sclerosismyelinprotectiontherapy

Substanzen

CuprizoneCopper

Autor:innen und Institutionen

  • Department of Anatomy & Physiology, The University of Melbourne, Victoria 3010, Australia.
  • Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Victoria 3010, Australia.
  • Atomic Medicine Initiative, University of Technology Sydney, Sydney, New South Wales 2007, Australia.
  • School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Victoria 3010, Australia.
  • School of Earth Sciences, The University of Melbourne, Victoria 3010, Australia.
  • Queensland Institute of Medical Research Berghofer, Herston, Queensland 4006, Australia.

Förderung

  • Michael Hirshorn Medical Research Commercialisation Fund
  • Australian Research Council
  • Agilent Technologies
  • NHMRC

Zitieren

APA

Hilton, J. B. W., Kysenius, K., Liddell, J. R., Mercer, S. W., Hare, D. J., Buncic, G., Paul, B., Wang, Y., Murray, S. S., Kilpatrick, T. J., White, A. R., Donnelly, P. S., & Crouch, P. J. (2024). Evidence for decreased copper associated with demyelination in the corpus callosum of cuprizone-treated mice. Metallomics. https://doi.org/10.1093/mtomcs/mfad072

Vancouver

Hilton JBW, Kysenius K, Liddell JR, Mercer SW, Hare DJ, Buncic G, et al. Evidence for decreased copper associated with demyelination in the corpus callosum of cuprizone-treated mice. Metallomics. 2024. doi:10.1093/mtomcs/mfad072

BibTeX
@article{Hilton2024,
  author = {Hilton, James B W and Kysenius, Kai and Liddell, Jeffrey R and Mercer, Stephen W and Hare, Dominic J and Buncic, Gojko and Paul, Bence and Wang, YouJia and Murray, Simon S and Kilpatrick, Trevor J and White, Anthony R and Donnelly, Paul S and Crouch, Peter J},
  title = {Evidence for decreased copper associated with demyelination in the corpus callosum of cuprizone-treated mice},
  journal = {Metallomics},
  year = {2024},
  doi = {10.1093/mtomcs/mfad072}
}
Kostenlos starten →